Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Oct 16;16(10):e256673.
doi: 10.1136/bcr-2023-256673.

Severe chronic diarrhoea caused by hereditary transthyretin amyloidosis

Affiliations
Case Reports

Severe chronic diarrhoea caused by hereditary transthyretin amyloidosis

Angelica Toppeta et al. BMJ Case Rep. .

Abstract

Amyloidosis includes a heterogeneous group of diseases caused by the extracellular deposition of insoluble fibrillar proteins, leading to multiple organ dysfunction and a poor life expectancy. In the early stages of amyloidosis, gastrointestinal (GI) symptoms are uncommon. We describe a rare case of hereditary transthyretin amyloidosis (ATTRv) with involvement of the heart, nervous system and GI tract. A man in his 60s was hospitalised due to chronic diarrhoea, orthostatic hypotension, malabsorption and weight loss. An organic origin for the diarrhoea was suspected, but the most common causes were ruled out. The review of GI biopsies and an abdominal fat aspirate confirmed the diagnosis of amyloidosis. The diagnosis of ATTRv amyloidosis with GI presentation is challenging, especially in the early stages, and misdiagnosis is common. The recent approval of therapies emphasises the importance of early diagnosis to prevent irreversible organ damage.

Keywords: Gastroenterology; Genetics; Malabsorption; Small intestine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Duodenum biopsy: Congo red-stained hyaline perivascular deposits.
Figure 2
Figure 2
Transthoracic echocardiography: cardiomyopathy-like picture of the left ventricle with slight concentric hypertrophy
Figure 3
Figure 3
Cardiac cine MRI of a left ventricle with thickened walls from hypertrophy, a distinct restrictive filling pattern and difficult myocardial signal washout in the sequences for late gadolinium enhancement

References

    1. Buxbaum JN, Dispenzieri A, Eisenberg DS, et al. . Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International society of Amyloidosis (ISA) nomenclature committee. Amyloid 2022;29:213–9. 10.1080/13506129.2022.2147636 - DOI - PubMed
    1. Matsuda M, Katoh N, Ikeda S. Clinical manifestations at diagnosis in Japanese patients with systemic AL Amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms.intern MED. Intern Med 2014;53:403–12. 10.2169/internalmedicine.53.0898 - DOI - PubMed
    1. Merlini G, Bellotti V. Molecular mechanisms of Amyloidosis. N Engl J Med 2003;349:583–96. 10.1056/NEJMra023144 - DOI - PubMed
    1. Sekijima Y. Transthyretin (ATTR) Amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 2015;86:1036–43. 10.1136/jnnp-2014-308724 - DOI - PubMed
    1. Adams D, Suhr OB, Hund E, et al. . Current opinion first European consensus for diagnosis, management, and treatment of Transthyretin familial Amyloid polyneuropathy. Curr Opin Neurol 2016;29 Suppl 1(Suppl 1):S14–26. 10.1097/WCO.0000000000000289 - DOI - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts